Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
Novello S, Kowalski DM, Luft A, Gümüş M, Vicente D, Mazières J, Rodríguez-Cid J, Tafreshi A, Cheng Y, Lee KH, Golf A, Sugawara S, Robinson AG, Halmos B, Jensen E, Schwarzenberger P, Pietanza MC, Paz-Ares L. Novello S, et al. Among authors: tafreshi a. J Clin Oncol. 2023 Apr 10;41(11):1999-2006. doi: 10.1200/JCO.22.01990. Epub 2023 Feb 3. J Clin Oncol. 2023. PMID: 36735893 Free PMC article. Clinical Trial.
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
Corrigendum to "Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study" [Eur Urol 83 (2023) 15-26].
Yu EY, Piulats JM, Gravis G, Fong PCC, Todenhöfer T, Laguerre B, Arranz JA, Oudard S, Massard C, Heinzelbecker J, Nordquist LT, Carles J, Kolinsky MP, Augustin M, Gurney H, Tafreshi A, Li XT, Qiu P, Poehlein CH, Schloss C, de Bono JS. Yu EY, et al. Among authors: tafreshi a. Eur Urol. 2023 Mar;83(3):e87. doi: 10.1016/j.eururo.2022.11.025. Epub 2022 Dec 15. Eur Urol. 2023. PMID: 36528479 Free article. No abstract available.
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.
Yap N, Wong V, Morton C, de Boer R, Baron-Hay S, Blum R, Forster B, Chua S, Clarke K, Cuff K, Green M, Lim E, Mok K, Nott L, Nottage M, Tafreshi A, Tsoi D, Uccellini A, Gibbs P, Lok SW. Yap N, et al. Among authors: tafreshi a. Intern Med J. 2024 Nov;54(11):1894-1897. doi: 10.1111/imj.16536. Epub 2024 Oct 28. Intern Med J. 2024. PMID: 39467087
Facile fabrication of novel magnetic chitosan-alginate @ pomegranate peel extract nanocomposite for the adsorptive removal of naphthalene from aqueous solutions.
Mohammadi AA, Marufi N, Hassan NE, Fallahizadeh S, Tafreshi A, Oskoei V, Ghanbari-Ghozikali M, Rezagholizade-Shirvan A. Mohammadi AA, et al. Among authors: tafreshi a. Int J Biol Macromol. 2024 Dec 7;287:138541. doi: 10.1016/j.ijbiomac.2024.138541. Online ahead of print. Int J Biol Macromol. 2024. PMID: 39653214
Effects of Probiotic Supplementation Added to a Weight Loss Program on Anthropometric Measures, Body Composition, Eating Behavior, and Related Hormone Levels in Patients with Food Addiction and Weight Regain After Bariatric Surgery: A Randomized Clinical Trial.
Ghafouri-Taleghani F, Tafreshi AS, Doost AH, Tabesh M, Abolhasani M, Amini A, Saidpour A. Ghafouri-Taleghani F, et al. Among authors: tafreshi as. Obes Surg. 2024 Sep;34(9):3181-3194. doi: 10.1007/s11695-024-07437-5. Epub 2024 Aug 8. Obes Surg. 2024. PMID: 39117856 Clinical Trial.
Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
Tucker DW, Pangal DJ, Du R, Gogia AS, Tafreshi A, Ruzevick J, Hurth KT, Triche T Jr, Micko A, Carpten JD, Shiroishi MS, Carmichael JD, Rhie SK, Zada G. Tucker DW, et al. Among authors: tafreshi a. PLoS One. 2023 Apr 27;18(4):e0284949. doi: 10.1371/journal.pone.0284949. eCollection 2023. PLoS One. 2023. PMID: 37104368 Free PMC article.
106 results